Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001537847 | SCV000536618 | uncertain significance | not provided | 2024-06-17 | criteria provided, single submitter | clinical testing | Has not been previously published in association with a NOTCH1-related phenotype to our knowledge; In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23860447, 24113472, 33918692, 24728327, 33735874) |
Labcorp Genetics |
RCV000539993 | SCV000659485 | likely benign | Adams-Oliver syndrome 5 | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000660177 | SCV000782171 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004649071 | SCV005142236 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-06-10 | criteria provided, single submitter | clinical testing | The c.6733G>A (p.G2245R) alteration is located in exon 34 (coding exon 34) of the NOTCH1 gene. This alteration results from a G to A substitution at nucleotide position 6733, causing the glycine (G) at amino acid position 2245 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
ITMI | RCV000121701 | SCV000085899 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |